Click a link below to view the mailing archive as if it had been sent to you.
| 2021-08-31 12:15 | | A year after a death and accompanying trial hold, Poseida hopes for reprieve with early solid tumor CAR-T data and more... |
| 2021-08-31 00:15 | | CDC scientist says there’s limited data to evaluate Covid booster doses for general population and more... |
| 2021-08-30 12:15 | | Reimbursement begins slowly for Biogen’s expensive Alzheimer’s drug and more... |
| 2021-08-30 00:15 | | Australia establishes first national biotech incubator and more... |
| 2021-08-29 00:15 | | Pharmacist-driven biosimilar substitution saves money and more... |
| 2021-08-27 12:15 | | Elizabeth Holmes fraud trial: What to expect in the case against the ex-Theranos CEO and more... |
| 2021-08-27 00:15 | | Gilead wins reversal of $1.2B fine in CAR-T patent fight with Bristol Myers and more... |
| 2021-08-26 12:15 | | After Ultomiris stumble, Alexion delivers a rare disease win for AZ and more... |
| 2021-08-26 00:15 | | MassBio Industry Snapshot Predicts 40,000 New Biopharma Jobs Over the Next 10 Years and more... |
| 2021-08-25 12:15 | | FibroGen, fresh off data manipulation scandal, touts win in cancer patients without revealing data and more... |
| 2021-08-25 00:15 | | American Medical Association calls for public, private sectors to mandate vaccines and more... |
| 2021-08-24 12:15 | | Mega $3 Billion+ Deal Shapes Up for Roche to Target AD and Parkinson's and more... |
| 2021-08-24 00:15 | | ESC: Amarin touts Vascepa's ability to reduce repeat heart problems as it fights generic with 'skinny label' claim and more... |
| 2021-08-23 12:15 | | Pfizer to acquire immuno-oncology company Trillium and more... |
| 2021-08-23 00:15 | | Small-Cap Biotech Stocks Are Having a Rough Year, But That Could Change in a Heartbeat and more... |
| 2021-08-21 00:15 | | The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday and more... |
| 2021-08-20 12:15 | | Get Ready for a Potential Double in This Biopharmaceutical Stock in the Next 6 to 12 Months and more... |
| 2021-08-20 00:15 | | Cell, gene therapy company funding reaches new heights, despite setbacks |
| 2021-08-19 12:15 | | J&J hunts for a Rybrevant label add just months after rare lung cancer approval and more... |
| 2021-08-19 00:15 | | Breathing Machine Recall Over Possible Cancer Risk Leaves Millions Scrambling for Substitutes and more... |
| 2021-08-18 12:15 | | Third Pfizer dose 86% effective in over 60s, Israeli HMO says and more... |
| 2021-08-18 00:15 | | Next-gen psoriasis drug rivalry between Bristol Myers and Nimbus spills into a legal battle and more... |
| 2021-08-17 12:15 | | Lilly, with Alzheimer's in its crosshairs, forms new neuroscience unit, unifies oncology under Loxo exec and more... |
| 2021-08-17 00:15 | | Abbott takes on competition with FDA approval of device to prevent afib-related strokes and more... |
| 2021-08-16 12:15 | | Thermo Fisher Wins EUA for Next-Gen COVID-19 Test as Delta Rages On and more... |
| 2021-08-16 00:15 | | The 6-Year Saga Finally Ends: FDA Issues Final Rule Modifying The Intended Use Regulation and more... |
| 2021-08-15 00:15 | | FDA new drug applications to cost more than $3M in 2022 and more... |
| 2021-08-14 00:15 | | Moderna's COVID-19 Vaccine Retains Antibodies Against Variants For 6 Months and more... |
| 2021-08-13 12:15 | | Facebook and YouTube execs say removing Covid-19 misinformation isn’t enough and more... |
| 2021-08-13 00:15 | | Medtech industry starts to face lack of diversity, execs of color and more... |
| 2021-08-12 12:15 | | Pfizer halted Chantix distribution then recalled a dozen batches. Now, a generic's here to help fill the shortage and more... |
| 2021-08-12 00:15 | | Purdue subsidiary buys non-opioid pain prospect from PureHealth and more... |
| 2021-08-11 12:15 | | Aiming to brush last year's flop aside, Fulcrum sees shares skyrocket on early look at sickle cell program and more... |
| 2021-08-11 00:15 | | Roche sets bar in early lymphoma treatment with Polivy study results and more... |
| 2021-08-10 12:15 | | Gilead latest biopharma company to require U.S. workers receive COVID-19 vaccine and more... |
| 2021-08-10 00:15 | | AbbVie hands back headline drug in $63B Allergan buyout to Molecular Partners after FDA rejection. What's next? and more... |
| 2021-08-09 12:15 | | India approves J&J’s single-dose Covid-19 vaccine for emergency use and more... |
| 2021-08-09 00:15 | | Bidding war breaks out for respiratory specialist Vectura and more... |
| 2021-08-08 12:15 | | Half Of U.S. Population Fully Vaccinated Against Covid-19, Says White House and more... |
| 2021-08-08 00:15 | | Boston Scientific Recalls Ingenio Pacemakers and CRT-Ps and more... |
| 2021-08-07 00:15 | | Sanofi and Regeneron solidify Dupixent TV ad lead, topping July pharma spenders again, trailed by AbbVie and Novo Nordisk and more... |
| 2021-08-06 12:15 | | Why COVID Vaccines for Younger Kids Won't Win Authorization as Soon as Expected and more... |
| 2021-08-06 00:15 | | Dicerna's RNAi drug shows 'inconsistent' results in rare kidney disease, tanking shares despite trial win and more... |
| 2021-08-05 12:15 | | Bayer bets $1.5B that Vividion will help it target the 'undruggable' and make 1+1=3 and more... |
| 2021-08-05 00:15 | | Can mRNA vaccines do for cancer what they did with Covid-19? and more... |
| 2021-08-04 12:15 | | Amgen vows to fight after IRS demands $3.6B in back taxes—and a bigger bill could be on the way and more... |
| 2021-08-04 00:15 | | Senate subcommittee advances FY2022 FDA funding bill and more... |
| 2021-08-03 12:15 | | Sanofi agrees to buy U.S. mRNA partner Translate Bio in $3.2 billion deal and more... |
| 2021-08-03 00:15 | | Bristol Myers pulls lymphoma indication for Istodax after confirmatory trial falls flat and more... |
| 2021-08-02 12:15 | | AstraZeneca nabs FDA nod to challenge GSK's Benlysta with first-in-class lupus drug Saphnelo and more... |
| 2021-08-02 00:15 | | Icosavax’s $182M IPO haul is key for RSV, but eyes are on its Covid vaccine too and more... |
| 2021-08-01 00:15 | | A pharma merger's impact ripples across West Virginia as Viatris plant closes and more... |
